5 Early-Stage Health Startups Bringing New Technology Into Hospitals

Why Exolumen stands out

Exolumen starts from technology with repeated operating-room use. Before incorporation, the Anatomy Projector that preceded its current platform had been used in more than 400 surgeries at Radboudumc. A randomized trial in 60 DIEP breast-reconstruction patients reported a 19-minute reduction in flap-harvest time versus Doppler ultrasound, tying the product thesis to operating-room time rather than only image quality.

A 2025 feasibility study added another technical signal: 82.1% of surgically identified vessels were within 3 cm of a projected thermal hotspot. Co-founder Stefan Hummelink developed the underlying projector in doctoral research, while Jeffrey van Rootseler brings hospital medication-management and commercial experience.

What Exolumen is building

Exolumen is building an image-guided surgery system, technology that uses medical images to help clinicians navigate anatomy and position instruments during an operation, around a projector that places anatomical information directly onto the patient. Its planning module projects vessel locations from pre-operative CT scans, while automatic movement correction is designed to keep the overlay aligned as the patient moves.

The platform also uses thermal sensing to capture skin-temperature patterns and project them back onto the operative field. The workflow is headset-free and gives the surgical team a shared view, reducing the need to translate information from a separate screen back onto the patient.

Why enamentis stands out

enamentis has moved Cir.Log from research into a recurring hospital workflow. The system is live at four hospitals across Germany, Austria and Switzerland, including a 12-month pilot at Universitätsspital Basel. Its direct integration with NEXUS EuroSDS lets staff launch the camera, review AI count results and confirm packed instruments inside existing reprocessing software rather than operate a separate standalone tool.

The technical base is also comparatively mature for an early-stage startup. Controlled imaging work reported up to 99.9% recognition accuracy across 156 instruments, and the platform recognizes more than 10,000 surgical instruments without markers. The founders developed the approach through years of machine-vision and automation work at Fraunhofer IPK.

The research-to-product path was supported by more than €1 million through EXIST Research Transfer, while the team now leads a €2.87 million federally funded SteriBot consortium with partners including Fraunhofer IPK.

What enamentis is building

Cir.Log is a retrofit camera for sterile processing, the hospital workflow for cleaning, inspecting, assembling and sterilizing reusable surgical instruments between procedures. Mounted above packing tables, it uses computer vision, AI-based image analysis that lets software identify and interpret objects or patterns in camera images, to recognize and count instruments locally and compare them with the required tray list.

The system works without tags, barcodes or RFID labels, can flag missing or incorrect items in real time and records packing results with images. enamentis is also automating loan-set intake and reports that the workflow can reduce manual booking work by up to 90%. Steri.Bot extends the same direction into robotics for instrument handling and reprocessing.

Why I See U Baby Care stands out

I See U Baby Care is addressing a monitoring problem where adding another sensor can itself create burden. Premature infants need frequent observation, but sleep state can be difficult to judge visually and routine care may interrupt rest. The startup secured a Dutch hospital collaboration in October 2025 and has built its product around non-contact observation rather than electrodes or wearables.

Founder Chanel Sam also brings direct research experience in premature-infant sleep. She co-authored the BeSSPI sleep-classification method, validated in 69 infants across 10,922 minutes of recordings, and earlier contributed to neonatal sleep research at UMC Utrecht and Wilhelmina Children’s Hospital.

What I See U Baby Care is building

The product uses a camera positioned above an incubator or bed to classify sleep and wake states in neonatal care, specialized care for newborn infants including premature or critically ill babies who may require intensive monitoring. Machine-learning models analyze movement and behavior without attaching another sensor to the infant.

The system is designed for real-time use in neonatal intensive care. Its federated-learning approach, a method for training a shared AI model across multiple sites while keeping sensitive raw data at each site, is intended to let models improve across hospitals without moving neonatal video out of each institution.

Why CCI Photonics stands out

CCI Photonics is trying to shorten the gap between collecting a sample and making an antibiotic decision. Its iiCON-supported pilot covered 739 biological samples, and a classifier trained on hundreds of clinical urine samples distinguished urosepsis from clean samples with near-80% accuracy. The startup has also raised £200,000 through PraeSeed and NPIF II.

The core technology is covered by an exclusive licence to work developed at Lancaster University, where co-founder Carlos Alejandro Meza Ramírez completed doctoral research in biospectroscopy. The founding team combines spectroscopy, microbiology and clinical infection-control experience.

What CCI Photonics is building

InfectiScan measures the infrared signature of a biological sample and applies machine-learning classifiers to identify infection patterns. The initial focus is urinary infection, with a longer-term goal of providing organism and antibiotic guidance near the point of care, testing performed near the patient rather than in a centralized laboratory.

The startup is working toward a stated 15-minute testing goal for pharmacies and clinics. The hospital relevance is the prescribing decision: antibiotic prescribing, the clinical decision about whether an antibiotic is needed and which one is most appropriate, becomes more useful when evidence arrives quickly enough to influence treatment. That matters in the context of antimicrobial resistance, the ability of microbes to survive medicines that would normally kill them or stop their growth.

Why Surgitec Robotics stands out

Surgitec Robotics is building around a hospital utilization problem as well as a surgical one. Bone procedures across brain, spine, face, joints and ear require millimeter-level precision, but robotic systems are often tied to one specialty. Surge One is designed as a shared platform that can support several hard-tissue specialties on the same system.

The team also brings direct deployment experience. Michel Lefranc helped co-develop ROSA and led the program at CHU Amiens-Picardie through its 100th robot-assisted spine procedure, while Florian Coiseur spent seven years at the startup that built ROSA. Surgitec Robotics has raised more than €8 million across 2024 and 2025 and has a published French patent application around contactless robot-to-patient alignment through imaging.

What Surgitec Robotics is building

Surge One is a surgical robotics platform, a robotic system that helps surgeons position tools or execute planned movements with high precision, for hard-tissue procedures across brain, spine, face and jaw, orthopedics and ENT. Rather than requiring a different robot for each specialty, the platform is designed to be shared across hospital departments.

Its contactless alignment workflow projects a laser line onto the patient and matches the observed shape to medical imaging, creating a route to robot-to-patient registration without attaching a tracking frame. The commercial logic therefore extends beyond technical accuracy to how often the system can be used across operating rooms and specialties.